HomeNDC LookupRxCUI directory › RxCUI 637518

Benzocaine 200 MG/ML / resorcinol 30 MG/ML Vaginal Cream — RxCUI 637518

RxNorm drug concept · Semantic clinical drug
RxCUI 637518 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 15 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI637518
Official nameBenzocaine 200 MG/ML / resorcinol 30 MG/ML Vaginal Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbenzocaine 20 % / resorcinol 3 % Vaginal Cream
FDA products mapped14
Package NDCs mapped15
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Benzocaine 200 MG/ML / resorcinol 30 MG/ML Vagin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Benzocaine 200 MG/ML / resorcinol 30 MG/ML Vaginal Cream RxCUI 637518

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Benzocaine 1399
    • Resorcinol 35382
    • Benzocaine / resorcinol 466427
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vagisil Original Formula 849739
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Benzocaine / resorcinol Vaginal Cream 377595
    • Benzocaine / resorcinol Vaginal Product 1152959
    • Benzocaine / resorcinol Vaginal Cream [Vagisil Original Formula] 849741
    • Vagisil Original Formula Vaginal Product 1187127
    • Vaginal Cream 11103
    • Vaginal Product 1151125
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Benzocaine 200 MG/ML SCDC · 328676
  • Resorcinol 30 MG/ML SCDC · 343219
  • Benzocaine / resorcinol Vaginal Cream SCDF · 377595
  • Benzocaine / resorcinol Vaginal Product SCDG · 1152959

Brand-Name Concepts

📦 FDA Products & Package NDCs

14 products · 15 package NDCs
15 package NDCs map to RxCUI 637518 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-2311-28 1 TUBE in 1 CARTON (0363-2311-28) / 28 g in 1 TUBE Anti-Itch Medicated Maximum Strength Walgreens Company 2018-07-19
11509-4402-01 1 TUBE in 1 CARTON (11509-4402-1) / 28 g in 1 TUBE VAGISIL Anti-Itch Medicated Creme Maximum Strength Combe Incorporated 1995-03-01
55621-0016-01 1 TUBE in 1 CARTON (55621-016-01) / 28 g in 1 TUBE Family Wellness Zhejiang Jingwei Pharmaceutic Al Co., Ltd. 2017-08-20
63868-0949-01 28 g in 1 TUBE (63868-949-01) Feminine Anti-Itch Creme Quality Choice (CHAIN DRUG MARKETING ASSOCIATION) 2020-02-01
69396-0183-01 1 TUBE in 1 BOX (69396-183-01) / 28.4 g in 1 TUBE Feminine Anti Itch Cream TRIFECTA PHARMACEUTICALS USA LLC 2026-05-01
69396-0183-33 3 TUBE in 1 BOX (69396-183-33) / 28.4 g in 1 TUBE Feminine Anti Itch Cream TRIFECTA PHARMACEUTICALS USA LLC 2026-05-01
71101-0035-01 28 g in 1 TUBE (71101-035-01) HealthWise Feminine Anti-itch Cream Veridian Healthcare 2024-05-01
71101-0039-01 28.3 g in 1 TUBE (71101-039-01) Caring Mills Vaginal Anti-Itch Cream Veridian Healthcare 2025-09-01
71101-0049-01 28 g in 1 TUBE (71101-049-01) HealthWise Feminine Anti-Itch Cream Veridian Healthcare 2024-08-01
71101-0065-01 28.3 g in 1 TUBE (71101-065-01) Caring Mills Vaginal Anti-Itch Cream Veridian Healthcare 2025-12-01
71101-0066-01 28.3 g in 1 TUBE (71101-066-01) HealthWise Feminine Anti-itch Cream Veridian Healthcare 2026-04-01
79481-0130-01 1 TUBE in 1 CARTON (79481-0130-1) / 28 g in 1 TUBE Meijer Vagicaine Meijer, Inc. 2025-03-03
79903-0233-01 1 TUBE in 1 CARTON (79903-233-01) / 28 g in 1 TUBE Equate Vagicaine Walmart Inc. 2023-12-01
80684-0142-00 28 g in 1 TUBE (80684-142-00) Thera Plus Maximum Strength Feminine Anti-Itch FOURSTAR GROUP USA, INC. 2025-02-26
83324-0019-01 28.3 g in 1 TUBE (83324-019-01) Maximum OTC Strength Feminine Anti-Itch Creme Quality Choice (CHAIN DRUG MARKETING ASSOCIATION) 2024-01-01
Observed labelers: Veridian Healthcare (5) · Quality Choice (CHAIN DRUG MARKETING ASSOCIATION) (2) · TRIFECTA PHARMACEUTICALS USA LLC (2) · Combe Incorporated (1) · FOURSTAR GROUP USA, INC. (1) · Meijer, Inc. (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.